Abstract
The latent membrane protein 1 (LMP1) encoded by the Epstein–Barr virus functions as a constitutively activated receptor of the tumor necrosis factor receptor family. LMP1 is a short-lived protein that is ubiquitinated and degraded by the proteasome. We have previously shown that LMP1 recruits the adapter protein tumor necrosis factor receptor-associated factor 3 (TRAF3) to lipid rafts. To test if TRAFs are involved in LMP1's ubiquitination, we have mutated the LMP1 CTAR1 site that has been identified as a TRAF binding site. We show that the CTAR1 mutant (CTAR1−) is expressed after transfection at a similar level to wild-type LMP1, and behaves as wild-type LMP1 with respect to membrane localization. However, CTAR1− does not bind TRAF3. We demonstrate that ubiquitination of CTAR1− is significantly reduced when compared to wild-type LMP1. In addition, the expression of wild-type LMP1 induces the ubiquitination, an effect that is significantly reduced when the CTAR1− is expressed. Taken together, our results suggest that TRAF proteins are involved in the ubiquitination of LMP1, and that their binding to LMP1 may facilitate their own ubiquitination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aviel S, Winberg G, Massucci M and Ciechanover A . (2000). J. Biol. Chem., 275, 23491–23499.
Baichwal VR and Sugden B . (1987). J. Virol., 61, 866–875.
Baichwal VR and Sugden B . (1988). Oncogene, 2, 461–467.
Bradley JR and Pober JS . (2001). Oncogene, 20, 6482–6491.
Brown DA and London E . (1998). Annu. Rev. Cell Dev. Biol., 14, 111–136.
Brown KD, Hostager BS and Bishop GA . (2001). J. Exp. Med., 193, 943–954.
Cherukuri A, Dykstra M and Pierce SK . (2001). Immunity, 14, 657–660.
Chung JY, Park YC, Ye H and Wu H . (2002). J. Cell Sci., 115, 679–688.
Ciechanover A, Orian A and Schwartz AL . (2000). J. Cell.Biochem. Suppl., 34, 40–51.
Clausse B, Fizazi K, Walczak V, Tetaud C, Wiels J, Tursz T and Busson P . (1997). Virology, 228, 285–293.
Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C and Chen ZJ . (2000). Cell, 103, 351–361.
Hammarskjold ML and Simurda MC . (1992). J. Virol., 66, 6496–6501.
Hicke L . (1999). Trends Cell Biol., 9, 107–112.
Higuchi M, Izumi KM and Kieff E . (2001). Proc. Natl. Acad. Sci. USA, 98, 4675–4680.
Hofmann RM and Pickart CM . (2001). J. Biol. Chem., 276, 27936–27943.
Ilangumaran S, He HT and Hoessli DC . (2000). Immunol. Today, 21, 2–7.
Joazeiro CA and Weissman AM . (2000). Cell, 102, 549–552.
Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V and Raab-Traub N . (1998). Proc. Natl. Acad. Sci. USA, 95, 11963–11968.
Lafont F and Simons K . (2001). Proc. Natl. Acad. Sci. USA, 98, 3180–3184.
Li X, Yang Y and Ashwell JD . (2002). Nature, 416, 345–347.
Mann KP and Thorley-Lawson D . (1987). J. Virol., 61, 2100–2108.
Martin J and Sugden B . (1991). J. Virol., 65, 3246–3258.
Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E . (1995). Cell, 80, 389–399.
Polekhina G, House CM, Traficante N, Mackay JP, Relaix F, Sassoon DA, Parker MW and Bowtell DD . (2002). Nat. Struct. Biol., 9, 68–75.
Rothenberger S, Rousseaux M, Knecht H, Bender FC, Legler DF and Bron C . (2002). Cell Mol. Life Sci., 59, 171–180.
Simons K and Toomre D . (2000). Nat.Mol.Cell Biol., 1, 31–38.
Strous GJ and Govers R . (1999). J. Cell Sci., 112(Pt 10), 1417–1423.
Wajant H, Henkler F and Scheurich P . (2001). Cell Signal., 13, 389–400.
Wang C, Deng L, Hong M, Akkaraju GR, Inoue J and Chen ZJ . (2001). Nature, 412, 346–351.
Wang D, Liebowitz D and Kieff E . (1985). Cell, 43, 831–840.
Ye H, Park YC, Kreishman M, Kieff E and Wu H . (1999). Mol. Cell, 4, 321–330.
Acknowledgements
The Swiss National Science Foundation (SNSF 31-61960.00) has supported this work. We thank Dr P Shaw and Dr M Thome for a critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rothenberger, S., Burns, K., Rousseaux, M. et al. Ubiquitination of the Epstein–Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 22, 5614–5618 (2003). https://doi.org/10.1038/sj.onc.1206497
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206497
Keywords
This article is cited by
-
Functional diversity: update of the posttranslational modification of Epstein–Barr virus coding proteins
Cellular and Molecular Life Sciences (2022)
-
Effects of partner proteins on BCA2 RING ligase activity
BMC Cancer (2012)
-
The TRAF3-binding site of human molluscipox virus FLIP molecule MC159 is critical for its capacity to inhibit Fas-induced apoptosis
Cell Death & Differentiation (2006)